See InMed Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Key Financial Ratios

Market Cap

4.63M

Dividend TTM

0.00

P/E TTM

-0.66

EPS TTM

-2.12

Revenue

Net Profit

-8.16M

ROE

-112.65%

ROA

-85.12%

InMed Pharmaceuticals Inc Earnings Date

Latest Release

May 6, 2026

EPS / Forecast

--/--

Revenue / Forecast

--/--

Financial Statement Highlights

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q4

FY2026Q3

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

Financial Indicators

EPS

-3.70%-1.24

62.14%-0.73

85.93%-0.51

99.19%-0.44

70.32%-1.20

46.01%-1.94

1.71%-3.64

-254.97%-54.11

-98.36%-4.04

70.15%-3.58

79.70%-3.71

81.20%-15.24

---2.04

---12.01

---18.27

---81.10

----

Revenue

----

-26.22%820.19K

-11.43%1.12M

1.69%1.30M

7.59%1.26M

-10.36%1.11M

40.23%1.26M

-44.48%1.28M

13.41%1.17M

163.99%1.24M

181.14%901.86K

348.96%2.31M

233.97%1.03M

77.22%469.78K

--320.79K

--514.76K

--309.58K

--265.09K

----

Net Profit

-226.53%-5.84M

-39.86%-2.97M

21.23%-2.03M

-2.92%-1.73M

7.71%-1.79M

-23.10%-2.12M

-74.20%-2.58M

33.86%-1.68M

-472.61%-1.94M

13.77%-1.72M

29.65%-1.48M

27.73%-2.54M

95.70%-338.39K

42.52%-2.00M

50.94%-2.10M

-18.12%-3.51M

-141.50%-7.87M

-12.06%-3.48M

-90.87%-4.28M

-85.83%-2.97M

Net Margin

----

-6.76%-247.29%

-16.20%-154.17%

9.24%-137.07%

-14.42%-168.12%

-94.34%-231.63%

52.83%-132.68%

-931.39%-151.02%

23.97%-146.93%

73.35%-119.19%

74.29%-281.29%

---14.64%

---193.24%

---447.25%

---1094.24%

----

Gross Margin

----

-56.45%15.97%

2.82%31.24%

25.26%40.15%

-71.88%5.63%

69.13%36.67%

915.80%30.38%

-51.16%32.06%

45.91%20.01%

24.05%21.68%

97.79%-3.72%

--65.64%

--13.72%

--17.48%

---168.36%

----

Income Statement

Revenue

----

-26.22%820.19K

-11.43%1.12M

1.69%1.30M

7.59%1.26M

-10.36%1.11M

40.23%1.26M

-44.48%1.28M

13.41%1.17M

163.99%1.24M

181.14%901.86K

348.96%2.31M

233.97%1.03M

77.22%469.78K

--320.79K

--514.76K

--309.58K

--265.09K

----

Operating profit

-74.32%-3.21M

-36.62%-2.82M

3.88%-2.12M

-0.54%-1.76M

8.31%-1.84M

-17.77%-2.12M

-29.41%-2.21M

33.16%-1.75M

-289.14%-2.01M

16.43%-1.80M

23.69%-1.70M

24.57%-2.62M

83.06%-516.26K

39.28%-2.15M

45.67%-2.23M

-20.28%-3.48M

7.83%-3.05M

-12.95%-3.54M

-112.59%-4.11M

-84.96%-2.89M

Net Profit

-226.53%-5.84M

-39.86%-2.97M

21.23%-2.03M

-2.92%-1.73M

7.71%-1.79M

-23.10%-2.12M

-74.20%-2.58M

33.86%-1.68M

-472.61%-1.94M

13.77%-1.72M

29.65%-1.48M

27.73%-2.54M

95.70%-338.39K

42.52%-2.00M

50.94%-2.10M

-18.12%-3.51M

-141.50%-7.87M

-12.06%-3.48M

-90.87%-4.28M

-85.83%-2.97M

Balance Sheet

Current assets

-79.20%2.68M

7.46%6.89M

60.67%8.79M

48.35%10.80M

48.08%12.87M

-36.31%6.41M

-53.68%5.47M

-12.24%7.28M

-23.32%8.69M

-15.02%10.06M

-15.75%11.81M

-28.14%8.30M

18.07%11.33M

35.39%11.84M

12.10%14.02M

-27.75%11.54M

14.56%9.60M

-19.73%8.75M

22.01%12.51M

--15.98M

Total current liabilities

6.27%1.96M

20.25%2.21M

-17.36%1.48M

8.29%1.55M

-6.70%1.84M

20.29%1.84M

6.57%1.79M

7.22%1.44M

-1.44%1.97M

-32.64%1.53M

-30.00%1.68M

-59.19%1.34M

-39.73%2.00M

-44.72%2.27M

-48.01%2.40M

70.32%3.28M

49.84%3.32M

139.49%4.11M

114.42%4.62M

--1.93M

Total assets

-80.55%3.03M

-1.57%9.13M

31.63%11.19M

27.67%13.36M

31.78%15.58M

-30.53%9.28M

-44.27%8.50M

-4.14%10.47M

-16.19%11.82M

-9.31%13.36M

-9.84%15.26M

-25.14%10.92M

10.31%14.11M

-4.88%14.73M

-12.71%16.92M

-15.83%14.58M

30.74%12.79M

25.44%15.49M

65.00%19.38M

--17.33M

Total liabilities

-8.88%1.96M

-0.72%2.24M

-30.88%1.60M

-14.46%1.77M

-18.00%2.15M

0.19%2.26M

-6.57%2.32M

54.54%2.07M

29.76%2.62M

-3.77%2.25M

-3.92%2.48M

-62.55%1.34M

-45.63%2.02M

-49.07%2.34M

-50.45%2.58M

69.85%3.58M

54.24%3.71M

138.23%4.60M

25.50%5.22M

--2.11M

Total equity

-92.00%1.08M

-1.85%6.89M

55.09%9.59M

38.06%11.59M

45.93%13.43M

-36.77%7.02M

-51.60%6.18M

-12.35%8.40M

-23.85%9.21M

-10.36%11.10M

-10.90%12.77M

-12.99%9.58M

33.17%12.09M

13.79%12.39M

1.18%14.34M

-27.68%11.01M

23.07%9.08M

4.53%10.89M

86.64%14.17M

--15.22M

Cash Flow Statement

Net operating income

-77.39%-3.15M

-82.14%-3.02M

5.03%-2.38M

12.00%-1.61M

-72.81%-1.78M

14.21%-1.66M

-35.39%-2.50M

15.98%-1.83M

-56.42%-1.03M

-16.76%-1.93M

31.88%-1.85M

3.61%-2.17M

83.74%-657.93K

69.03%-1.66M

23.22%-2.71M

15.01%-2.26M

-101.75%-4.05M

-15.99%-5.35M

---3.53M

-93.49%-2.65M

Net investment

--0.00

100.00%0.00

--0.00

100.00%0.00

100.00%-2.00

98.14%-9.29K

--0.00

95.37%-33.61K

-3508.16%-128.20K

-263.39%-500.00K

100.00%0.00

-41955.48%-725.46K

---3.55K

--306.01K

---250.00K

Net financing

-100.00%-1.00

-92.07%231.68K

-100.00%0.00

-116.37%-137.18K

4644531.25%8.17M

--2.92M

-92.73%338.52K

--838.24K

--176.00

100.00%0.00

-12.44%4.65M

-100.00%0.00

-117.31%-63.70K

735.69%5.32M

-50.12%5.43M

6172.97%5.05M

-100.72%-29.31K

---836.14K

16936.86%10.88M

FAQs

What are the current assets of InMed Pharmaceuticals Inc?



According to InMed Pharmaceuticals Inc's FY2026 earnings report, its current assets were 2.68M, with a year-on-year change of -79.20.

What are the total assets of InMed Pharmaceuticals Inc?



According to InMed Pharmaceuticals Inc's FY2026 earnings report, its total assets of InMed Pharmaceuticals Inc were 3.03M, with a year-on-year change of -80.55.

What are the total liabilities of InMed Pharmaceuticals Inc?



According to InMed Pharmaceuticals Inc's FY2026 earnings report, its total liabilities of InMed Pharmaceuticals Inc were 1.96M, with a year-on-year change of -8.88.

What is the total equity of InMed Pharmaceuticals Inc?



According to InMed Pharmaceuticals Inc's FY2026 earnings report, its total equity of InMed Pharmaceuticals Inc was 1.08M, with a year-on-year change of -92.00.

What is the net operating income of InMed Pharmaceuticals Inc?



According to InMed Pharmaceuticals Inc's FY2026 earnings report, its net operating income of InMed Pharmaceuticals Inc was -9.90M, with a year-on-year change of -24.97.

What is the net financing of InMed Pharmaceuticals Inc?



According to InMed Pharmaceuticals Inc's FY2026 earnings report, its net financing of InMed Pharmaceuticals Inc was 94.50K, with a year-on-year change of -99.23.

What is the Earnings Per Share (EPS) of InMed Pharmaceuticals Inc?



According to InMed Pharmaceuticals Inc's FY2026 earnings report, its Earnings Per Share (EPS) was -3.02, with a year-on-year change of 63.93.

What is the net income of InMed Pharmaceuticals Inc?



According to InMed Pharmaceuticals Inc's FY2026 earnings report, its net income was -12.56M, with a year-on-year change of -53.89.

What is the Return on Equity (ROE) of InMed Pharmaceuticals Inc?



According to InMed Pharmaceuticals Inc's FY2026 earnings report, its Return on Equity (ROE) was -156.77, with a year-on-year change of -117.43.

What is the Return on Assets (ROA) of InMed Pharmaceuticals Inc?



According to InMed Pharmaceuticals Inc's FY2026 earnings report, its Return on Assets (ROA) was -122.23, with a year-on-year change of -105.17.

What is the operating profit of InMed Pharmaceuticals Inc?



According to InMed Pharmaceuticals Inc's FY2026 earnings report, its operating profit was -9.90M, with a year-on-year change of -24.97.